미만성 거대 B-세포 림프종을 치료하기 위한 항-CD79b 면역접합체의 사용 방법
본 발명은 항-CD79b 항체를 포함하는 면역접합체를 항-CD20 항체(예를 들어, 리툭시맙) 및 하나 이상의 화학요법제(예를 들어, 젬시타빈 및 옥살리플라틴)와 병용하여 B-세포 증식성 장애(예를 들어, 미만성 거대 B-세포 림프종(DLBCL))를 치료하는 방법을 제공한다. Provided herein are methods of treating B-cell proliferative disorders (such as diffuse large B-cell lymphoma (DLBCL)) using immunoconjugates com...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | QAYUM NASEER UL DIN HIRATA JAMIE HARUE HERNANDEZ MONTALVO JUANA ELVA |
| description | 본 발명은 항-CD79b 항체를 포함하는 면역접합체를 항-CD20 항체(예를 들어, 리툭시맙) 및 하나 이상의 화학요법제(예를 들어, 젬시타빈 및 옥살리플라틴)와 병용하여 B-세포 증식성 장애(예를 들어, 미만성 거대 B-세포 림프종(DLBCL))를 치료하는 방법을 제공한다.
Provided herein are methods of treating B-cell proliferative disorders (such as diffuse large B-cell lymphoma (DLBCL)) using immunoconjugates comprising anti-CD79b antibodies in combination with an anti-CD20 antibody (such as rituximab) and one or more chemotherapeutic agents (such as gemcitabine and oxaliplatin). |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20220086618A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20220086618A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20220086618A3</originalsourceid><addsrcrecordid>eNrjZEh9vX7H6-U9b1o2KrzauOF1T4OCk-6blh1v-9covF625-2UljeLWt_MbVF4s3PG68U9b6fOeLVjg8KbOS1vp85ReDt1ra6zi7llksLrlVveTF_7ZsHEt1NXvtm05c3cGQpvmta8mbVS4fWGla83TeVhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHeQUYGRkYGBhZmZoYWjsbEqQIAlZdZ5g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>미만성 거대 B-세포 림프종을 치료하기 위한 항-CD79b 면역접합체의 사용 방법</title><source>esp@cenet</source><creator>QAYUM NASEER UL DIN ; HIRATA JAMIE HARUE ; HERNANDEZ MONTALVO JUANA ELVA</creator><creatorcontrib>QAYUM NASEER UL DIN ; HIRATA JAMIE HARUE ; HERNANDEZ MONTALVO JUANA ELVA</creatorcontrib><description>본 발명은 항-CD79b 항체를 포함하는 면역접합체를 항-CD20 항체(예를 들어, 리툭시맙) 및 하나 이상의 화학요법제(예를 들어, 젬시타빈 및 옥살리플라틴)와 병용하여 B-세포 증식성 장애(예를 들어, 미만성 거대 B-세포 림프종(DLBCL))를 치료하는 방법을 제공한다.
Provided herein are methods of treating B-cell proliferative disorders (such as diffuse large B-cell lymphoma (DLBCL)) using immunoconjugates comprising anti-CD79b antibodies in combination with an anti-CD20 antibody (such as rituximab) and one or more chemotherapeutic agents (such as gemcitabine and oxaliplatin).</description><language>kor</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220623&DB=EPODOC&CC=KR&NR=20220086618A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220623&DB=EPODOC&CC=KR&NR=20220086618A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>QAYUM NASEER UL DIN</creatorcontrib><creatorcontrib>HIRATA JAMIE HARUE</creatorcontrib><creatorcontrib>HERNANDEZ MONTALVO JUANA ELVA</creatorcontrib><title>미만성 거대 B-세포 림프종을 치료하기 위한 항-CD79b 면역접합체의 사용 방법</title><description>본 발명은 항-CD79b 항체를 포함하는 면역접합체를 항-CD20 항체(예를 들어, 리툭시맙) 및 하나 이상의 화학요법제(예를 들어, 젬시타빈 및 옥살리플라틴)와 병용하여 B-세포 증식성 장애(예를 들어, 미만성 거대 B-세포 림프종(DLBCL))를 치료하는 방법을 제공한다.
Provided herein are methods of treating B-cell proliferative disorders (such as diffuse large B-cell lymphoma (DLBCL)) using immunoconjugates comprising anti-CD79b antibodies in combination with an anti-CD20 antibody (such as rituximab) and one or more chemotherapeutic agents (such as gemcitabine and oxaliplatin).</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZEh9vX7H6-U9b1o2KrzauOF1T4OCk-6blh1v-9covF625-2UljeLWt_MbVF4s3PG68U9b6fOeLVjg8KbOS1vp85ReDt1ra6zi7llksLrlVveTF_7ZsHEt1NXvtm05c3cGQpvmta8mbVS4fWGla83TeVhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHeQUYGRkYGBhZmZoYWjsbEqQIAlZdZ5g</recordid><startdate>20220623</startdate><enddate>20220623</enddate><creator>QAYUM NASEER UL DIN</creator><creator>HIRATA JAMIE HARUE</creator><creator>HERNANDEZ MONTALVO JUANA ELVA</creator><scope>EVB</scope></search><sort><creationdate>20220623</creationdate><title>미만성 거대 B-세포 림프종을 치료하기 위한 항-CD79b 면역접합체의 사용 방법</title><author>QAYUM NASEER UL DIN ; HIRATA JAMIE HARUE ; HERNANDEZ MONTALVO JUANA ELVA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20220086618A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>kor</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>QAYUM NASEER UL DIN</creatorcontrib><creatorcontrib>HIRATA JAMIE HARUE</creatorcontrib><creatorcontrib>HERNANDEZ MONTALVO JUANA ELVA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>QAYUM NASEER UL DIN</au><au>HIRATA JAMIE HARUE</au><au>HERNANDEZ MONTALVO JUANA ELVA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>미만성 거대 B-세포 림프종을 치료하기 위한 항-CD79b 면역접합체의 사용 방법</title><date>2022-06-23</date><risdate>2022</risdate><abstract>본 발명은 항-CD79b 항체를 포함하는 면역접합체를 항-CD20 항체(예를 들어, 리툭시맙) 및 하나 이상의 화학요법제(예를 들어, 젬시타빈 및 옥살리플라틴)와 병용하여 B-세포 증식성 장애(예를 들어, 미만성 거대 B-세포 림프종(DLBCL))를 치료하는 방법을 제공한다.
Provided herein are methods of treating B-cell proliferative disorders (such as diffuse large B-cell lymphoma (DLBCL)) using immunoconjugates comprising anti-CD79b antibodies in combination with an anti-CD20 antibody (such as rituximab) and one or more chemotherapeutic agents (such as gemcitabine and oxaliplatin).</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | kor |
| recordid | cdi_epo_espacenet_KR20220086618A |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 미만성 거대 B-세포 림프종을 치료하기 위한 항-CD79b 면역접합체의 사용 방법 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T15%3A29%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=QAYUM%20NASEER%20UL%20DIN&rft.date=2022-06-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20220086618A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |